Jan 7, 2023 · Credit: Juan Gaertner/SPL. The US Food and Drug Administration (FDA) has approved lecanemab, the second-ever treatment for Alzheimer’s disease that is intended to tackle the root of the ... There may not be an obvious cause. But many times, there are triggers you can spot before or during a problem. Common ones include: Discomfort from lack of sleep, side effects from medication, or ... Aug 31, 2023 · Read the latest research on Alzheimer's disease. Learn about Alzheimer's symptoms such as memory loss and senile dementia. Find out about Alzheimer's stages, causes and new treatments. Aug 30, 2023 · Expertise and rankings. Each year, Mayo Clinic doctors care for more than 1,900 people with Alzheimer's disease. The Mayo Clinic Alzheimer's Disease Research Center is jointly based in Rochester, Minnesota, and Jacksonville, Florida. These facilities — two of 33 centers designated and funded by the National Institute on Aging — enable Mayo ... Apr 23, 2022 · Unfortunately, the short answer is no—mood stabilizers have not been found effective for treating dementia, and some may even cause harm. Several different medications—many of which are anticonvulsants (drugs to reduce seizures)—are classified as mood stabilizers. In general, research has not supported widespread use of mood stabilizers ... There are three drugs of this type: donepezil ( Aricept ), galantamine ( Razadyne ), and rivastigmine ( Exelon ). Aricept is the only treatment approved by the FDA for all stages of Alzheimer’s ...Aggressive behaviors may be verbal or physical. They can occur suddenly, with no apparent reason, or result from a frustrating situation. While aggression can be hard to cope with, understanding that the person with Alzheimer's or dementia is not acting this way on purpose can help. Causes. How to respond. Alzheimer disease is the most common form of dementia, affecting more than one-third of Americans older than 85 years. It is characterized by progressive memory loss and cognitive decline. Amyloid ...The main use of cholinesterase inhibitors is for the treatment of dementia in patients with Alzheimer's disease. People with Alzheimer's disease have reduced levels of acetylcholine in the brain. Cholinesterase inhibitors have been shown to have a modest effect on dementia symptoms such as cognition.Aug 30, 2023 · Infections and immune disorders. Dementia-like symptoms can result from a fever or other side effects of the body's attempt to fight off an infection. Multiple sclerosis and other conditions caused by the body's immune system attacking nerve cells also can cause dementia. Metabolic or endocrine problems. Jun 1, 2018 · Alzheimer disease is the most common form of dementia. In 2016, an estimated 5.2 million Americans age 65 and older had Alzheimer disease. The prevalence is projected to increase to 13.8 million by 2050, including 7 million people age 85 and older. 1. Although no cure for dementia exists, several cognition-enhancing drugs have been approved by ... Compare risks and benefits of common medications used for Alzheimer's Disease. Find the most ... Medications are often prescribed to help keep blood pressure low, one of the best ways to avoid further strokes. Mixed dementia. Mixed dementia is a combination of two or more types of dementia. People with Alzheimer’s disease, for example, may experience a stroke that leaves them with more cognitive issues than the Alzheimer’s alone came with. Aducanumab (Aduhelm®) has received accelerated approval as a treatment for Alzheimer’s disease from the U.S. Food and Drug Administration (FDA). Aducanumab was the first therapy to demonstrate that removing beta-amyloid, one of the hallmarks of Alzheimer’s disease, from the brain reduces cognitive and functional decline in people living ... Drugs used to treat Alzheimer's Disease The following list of medications are in some way related to or used in the treatment of this condition. Show filters 1 2 Next View all results on one page Frequently asked questions What is Quercetin and what are its health benefits? What's the mechanism of action for Leqembi (lecanemab-irmb)?Jan 11, 2023 · On January 6th, the Food and Drug Administration approved, via the Accelerated Approval pathway, a new treatment for Alzheimer’s disease called Leqembi. While older Alzheimer’s drugs may ease symptoms for a time, they do nothing to stop the relentless downward course of the disease. Leqembi is the second of a ... Jun 7, 2021 · The Food and Drug Administration on Monday approved Biogen ’s Alzheimer’s disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people ... Alzheimer disease is the most common form of dementia, affecting more than one-third of Americans older than 85 years. It is characterized by progressive memory loss and cognitive decline. Amyloid ...The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia.Sep 6, 2023 · Overview of using medications to treat anxiety in Alzheimer's patients. Medications for treating anxiety. Anxiety symptoms are fairly common among patients with Alzheimer's Disease (AD). Such symptoms are likely to make patient care more problematic and, therefore, increase the risk of nursing home placement. EVIDENCE-BASED ANSWER. ATYPICAL ANTIPSYCHOTICS ARE EFFECTIVE; so are selective serotonin reuptake inhibitors (SSRIs), and they may be safer. Atypical antipsychotics are an effective short-term (6-12 weeks) treatment for aggressive behavior in patients with Alzheimer’s disease because they consistently decrease aggression scores (strength of recommendation [SOR]: A, multiple randomized ...People with Alzheimer’s disease may become agitated or aggressive as the disease gets worse. Agitation means that a person is restless or worried. He or she doesn’t seem to be able to settle down. Agitation may cause pacing, sleeplessness, or aggression, which is when a person lashes out verbally or tries to hit or hurt someone.The Food and Drug Administration on Monday approved Biogen 's Alzheimer's disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people ...Aug 30, 2023 · While Alzheimer's drugs don't cure the disease, they can improve quality of life and help prolong independence. There are two types of medications approved to treat Alzheimer's: those that can temporarily ease some symptoms, and those that can slow the progression of the disease. The most common treatment for depression in Alzheimer's involves a combination of medicine, counseling, and gradual reconnection to activities and people that bring happiness. Simply telling the person with Alzheimer's to "cheer up," "snap out of it" or "try harder" is seldom helpful.Jan 22, 2021 · Treatment for Alzheimer's disease, the devastating condition that affects more than 5 million Americans, has remained notoriously elusive for decades. Now, a small study released by drug company Eli Lilly offers at least a flicker of hope: It shows that the experimental drug donanemab may significantly slow patients’ cognitive decline. Jun 7, 2021 · Matt York/AP. The Food and Drug Administration approved the drug aducanumab to treat patients with Alzheimer's disease on Monday. It is the first new drug approved by the agency for Alzheimer's ... Huperzine A. Huperzine A (pronounced HOOP-ur-zeen) is a moss extract that has been used in traditional Chinese medicine for centuries. It has properties similar to those of cholinesterase inhibitors, one class of FDA-approved Alzheimer's medications. As a result, it is promoted as a treatment for Alzheimer's disease.Antipsychotic medications can treat dementia symptoms such as aggression or psychosis. But these drugs can cause serious side effects. ... Alzheimer’s disease is the most common form of dementia ...Evidence Summary. A 2018 meta-analysis examining medications used to alleviate agitation in all types of dementia included 36 RCTs with a total of 5,585 participants (mean age = 81.8 years ± 4.9 ...Evidence Summary. A 2018 meta-analysis examining medications used to alleviate agitation in all types of dementia included 36 RCTs with a total of 5,585 participants (mean age = 81.8 years ± 4.9 ...Feb 18, 2022 · However, there is hope for an Alzheimer’s cure breakthrough 2022. Currently, Aducanumab is only approved for use in select patients with mild cognitive impairment or early Alzheimer’s disease. Before the treatment can be administered, all individuals with AD must undergo a PET scan to determine if they have amyloid plaques. The cholinesterase inhibitors are the main first-line treatment for Alzheimer’s disease. These drugs attempt to make up for depleted levels of acetylcholine. For moderate to severe disease, doctors often add the NMDA receptor drug. Researchers are still exploring the exact role of the new MAB drug. Aducanumab (Aduhelm) is a MAB and is the ...Sep 16, 2020 · A new study suggests anticholinergic medications may increase the risk of accelerated cognitive decline, especially in older adults at high risk of developing Alzheimer’s disease. A recent study ... Aug 30, 2022 · Antipsychotic medications can treat dementia symptoms such as aggression or psychosis. But these drugs can cause serious side effects. ... Alzheimer’s disease is the most common form of dementia ... Dec 3, 2021 · Manage medications. Some antidepressant medications, such as bupropion and venlafaxine, can lead to insomnia. Cholinesterase inhibitors, such as donepezil, can improve cognitive and behavioral symptoms in people with Alzheimer's but also can cause insomnia. If the person with dementia is taking these kinds of medications, talk to the doctor. Jun 7, 2021 · June 07, 2021. Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was ... Matt York/AP. The Food and Drug Administration approved the drug aducanumab to treat patients with Alzheimer's disease on Monday. It is the first new drug approved by the agency for Alzheimer's ...In the early stages of Alzheimer's, the person with dementia may need help remembering to take medications. As a caregiver, you may find it helpful to: Use a pill box organizer. Using a pill box or keeping a daily list or calendar can help ensure medication is taken as prescribed. Develop a routine for giving the medication.May 7, 2022 · Chronic alcoholism can seriously impair mental abilities. Alcohol can also cause memory loss by interacting with medications. Vitamin B-12 deficiency. Vitamin B-12 helps maintain healthy nerve cells and red blood cells. A vitamin B-12 deficiency — common in older adults — can cause memory problems. Hypothyroidism. The late stage of Alzheimer's disease may last from several weeks to several years. As the disease progresses, intensive, around-the-clock care is usually required. What to expect. Bowel and bladder function. Your role as caregiver. Skin and body health. Late-stage care options. Infections and pneumonia. Food and fluids.The most common treatment for depression in Alzheimer's involves a combination of medicine, counseling, and gradual reconnection to activities and people that bring happiness. Simply telling the person with Alzheimer's to "cheer up," "snap out of it" or "try harder" is seldom helpful. It's characterized by changes in the brain that lead to deposits of certain proteins. Alzheimer's disease causes the brain to shrink and brain cells to eventually die. Alzheimer's disease is the most common cause of dementia — a gradual decline in memory, thinking, behavior and social skills. These changes affect a person's ability to function.EVIDENCE-BASED ANSWER. ATYPICAL ANTIPSYCHOTICS ARE EFFECTIVE; so are selective serotonin reuptake inhibitors (SSRIs), and they may be safer. Atypical antipsychotics are an effective short-term (6-12 weeks) treatment for aggressive behavior in patients with Alzheimer’s disease because they consistently decrease aggression scores (strength of recommendation [SOR]: A, multiple randomized ... Jun 7, 2021 · June 07, 2021. Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was ... Jul 29, 2022 · Lorazepam (Ativan) Oxazepam (Serax) Alprazolam (Xanax) Alternative medications. Paying for medication. Summary. Antianxiety medications can help reduce anxiety in people living with dementia ... medications may help lessen symptoms, such as memory loss and confusion. FDA-approved drugs for Alzheimer's The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia. Jan 14, 2022 · The increase in the premium – from $148.50 in 2021 to $170.10 in 2022 – was based on a “high-cost” scenario that took into account the potential increase in Medicare Part B spending for ... May 12, 2023 · Drug approval process for the treatment of Alzheimer’s disease. Alzheimer Society of Canada. Get the full picture of how a drug gets approved for public use in Canada, including a list of the currently approved medications that can treat the symptoms of Alzheimer's. Treatment options. Alzheimer Society of Canada. Allow the medicine a few weeks to take effect. It is recommended that people with Alzheimer's should NOT take anticholinergic drugs. These drugs are used to treat many medical problems such as sleeping problems, stomach cramps, incontinence, asthma, motion sickness, and muscle spasms. Side effects, such as confusion, can be serious for a person ...Aug 31, 2023 · Read the latest research on Alzheimer's disease. Learn about Alzheimer's symptoms such as memory loss and senile dementia. Find out about Alzheimer's stages, causes and new treatments. Lecanemab and aducanumab are immunotherapies with FDA Accelerated Approval to treat early Alzheimer’s. These drugs target the protein beta-amyloid to help reduce amyloid plaques, one of the hallmark brain changes in Alzheimer’s.Apr 24, 2023 · Alzheimer’s disease is a progressive neurodegenerative disorder that affects memory, thinking, behavior, and ultimately, a person’s ability to carry out daily activities. Jan 11, 2023 · On January 6th, the Food and Drug Administration approved, via the Accelerated Approval pathway, a new treatment for Alzheimer’s disease called Leqembi. While older Alzheimer’s drugs may ease symptoms for a time, they do nothing to stop the relentless downward course of the disease. Leqembi is the second of a ... Aggressive behaviors may be verbal or physical. They can occur suddenly, with no apparent reason, or result from a frustrating situation. While aggression can be hard to cope with, understanding that the person with Alzheimer's or dementia is not acting this way on purpose can help. Causes. How to respond. Matt York/AP. The Food and Drug Administration approved the drug aducanumab to treat patients with Alzheimer's disease on Monday. It is the first new drug approved by the agency for Alzheimer's ...Compare risks and benefits of common medications used for Alzheimer's Disease. Find the most ... Jan 11, 2023 · On January 6th, the Food and Drug Administration approved, via the Accelerated Approval pathway, a new treatment for Alzheimer’s disease called Leqembi. While older Alzheimer’s drugs may ease symptoms for a time, they do nothing to stop the relentless downward course of the disease. Leqembi is the second of a ... A neurological exam may include testing: Reflexes. Muscle tone and strength. Ability to get up from a chair and walk across the room. Sense of sight and hearing. Coordination. Balance. Lab tests Blood tests may help rule out other potential causes of memory loss and confusion, such as a thyroid disorder or vitamin levels that are too low.Compare risks and benefits of common medications used for Alzheimer's Disease. Find the most ... Manage medications. Some antidepressant medications, such as bupropion and venlafaxine, can lead to insomnia. Cholinesterase inhibitors, such as donepezil, can improve cognitive and behavioral symptoms in people with Alzheimer's but also can cause insomnia. If the person with dementia is taking these kinds of medications, talk to the doctor.Apr 24, 2023 · Alzheimer’s disease is a progressive neurodegenerative disorder that affects memory, thinking, behavior, and ultimately, a person’s ability to carry out daily activities. Lecanemab and aducanumab are immunotherapies with FDA Accelerated Approval to treat early Alzheimer’s. These drugs target the protein beta-amyloid to help reduce amyloid plaques, one of the hallmark brain changes in Alzheimer’s.In the early stages of Alzheimer's, the person with dementia may need help remembering to take medications. As a caregiver, you may find it helpful to: Use a pill box organizer. Using a pill box or keeping a daily list or calendar can help ensure medication is taken as prescribed. Develop a routine for giving the medication.Aug 30, 2023 · In 2023, the U.S. Food and Drug Administration (FDA) approved lecanemab (Leqembi) for people with mild Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease. A phase 3 clinical trial found that the medicine slowed cognitive decline in people with early Alzheimer's disease. There's currently no cure for Alzheimer's disease. But there is medicine available that can temporarily reduce the symptoms. Support is also available to help someone with the condition, and their family, cope with everyday life. Medicines. A number of medicines may be prescribed for Alzheimer's disease to help temporarily improve some symptoms.The Food and Drug Administration on Thursday fully approved the Alzheimer’s drug Leqembi, amid concerns about its safety, cost and accessibility. The move marks the first time that a drug meant ...It's characterized by changes in the brain that lead to deposits of certain proteins. Alzheimer's disease causes the brain to shrink and brain cells to eventually die. Alzheimer's disease is the most common cause of dementia — a gradual decline in memory, thinking, behavior and social skills. These changes affect a person's ability to function.Antipsychotic medications can treat dementia symptoms such as aggression or psychosis. But these drugs can cause serious side effects. ... Alzheimer’s disease is the most common form of dementia ...Dementia can’t be cured, but several medications can help control some of its symptoms. Learn about 4 common dementia medications here. Also discover why drugs for Alzheimer’s disease may be ...The main use of cholinesterase inhibitors is for the treatment of dementia in patients with Alzheimer's disease. People with Alzheimer's disease have reduced levels of acetylcholine in the brain. Cholinesterase inhibitors have been shown to have a modest effect on dementia symptoms such as cognition.In June 2021, the Food and Drug Administration approved Aduhelm (aducanumab) as another option to treat Alzheimer’s disease. Aduhelm is the first new drug approved for the disease since 2003 as well as the first to specifically target amyloid-beta, the protein researchers widely believe to play a role in the development of Alzheimer's.Lorazepam (Ativan) Oxazepam (Serax) Alprazolam (Xanax) Alternative medications. Paying for medication. Summary. Antianxiety medications can help reduce anxiety in people living with dementia ...Common medications can cause dementia-like symptoms. Common prescription and over-the-counter medications called anticholinergics (anti-col-in-er-jikhear it) have side effects that can worsen existing Alzheimer’sdementia symptoms. This type of drug can even cause dementia-like symptoms cognitive impairment. start, stop, or adjust the dosage ... Feb 18, 2022 · However, there is hope for an Alzheimer’s cure breakthrough 2022. Currently, Aducanumab is only approved for use in select patients with mild cognitive impairment or early Alzheimer’s disease. Before the treatment can be administered, all individuals with AD must undergo a PET scan to determine if they have amyloid plaques. The FDA has approved medications that fall into two categories: drugs that change disease progression in people living with early Alzheimer's disease, and drugs that may temporarily mitigate some symptoms of Alzheimer's dementia.The main use of cholinesterase inhibitors is for the treatment of dementia in patients with Alzheimer's disease. People with Alzheimer's disease have reduced levels of acetylcholine in the brain. Cholinesterase inhibitors have been shown to have a modest effect on dementia symptoms such as cognition.Compare risks and benefits of common medications used for Alzheimer's Disease. Find the most ... Create a calm place for them. Cut out background noise from the TV or radio, clear away clutter, and make their daily tasks as simple as possible. Check for physical reasons they might be agitated ...Aug 3, 2022 · Treatments for Alzheimer’s Disease. Learn more about initial patient support strategies, the latest approved drugs to slow the disease’s progress, and the status of new clinical trials. The Food and Drug Administration on Thursday fully approved the Alzheimer’s drug Leqembi, amid concerns about its safety, cost and accessibility. The move marks the first time that a drug meant ...Create a calm place for them. Cut out background noise from the TV or radio, clear away clutter, and make their daily tasks as simple as possible. Check for physical reasons they might be agitated ... Family members often want their loved one to continue on dementia meds. Alzheimer’s advocate Meryl Comer, who cared for her husband with early onset AD at home throughout his illness (see Aug 2014 news story), noted that the drugs seemed to help control his symptoms. “Memantine made him more cooperative, and that made the difference between ... Even though the chief cause of behavioral symptoms is the effect of Alzheimer's disease on the brain, an examination may reveal other treatable conditions that are contributing to the behavior. Contributing conditions may include: Drug side effects. Many people with Alzheimer's take prescription medications for other health issues.In 2023, the U.S. Food and Drug Administration (FDA) approved lecanemab (Leqembi) for people with mild Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease. A phase 3 clinical trial found that the medicine slowed cognitive decline in people with early Alzheimer's disease.The most common treatment for depression in Alzheimer's involves a combination of medicine, counseling, and gradual reconnection to activities and people that bring happiness. Simply telling the person with Alzheimer's to "cheer up," "snap out of it" or "try harder" is seldom helpful.Create a calm place for them. Cut out background noise from the TV or radio, clear away clutter, and make their daily tasks as simple as possible. Check for physical reasons they might be agitated ...For sleep changes due primarily to Alzheimer’s disease, there are non-drug and drug approaches to treatment. Most experts and the National Institutes of Health (NIH) strongly encourage use of non-drug measures rather than medication. Studies have found that sleep medications generally do not improve overall sleep quality for older adults. Manage medications. Some antidepressant medications, such as bupropion and venlafaxine, can lead to insomnia. Cholinesterase inhibitors, such as donepezil, can improve cognitive and behavioral symptoms in people with Alzheimer's but also can cause insomnia. If the person with dementia is taking these kinds of medications, talk to the doctor.
Evidence Summary. A 2018 meta-analysis examining medications used to alleviate agitation in all types of dementia included 36 RCTs with a total of 5,585 participants (mean age = 81.8 years ± 4.9 ... . Mr_1e.htm
Aug 31, 2023 · Read the latest research on Alzheimer's disease. Learn about Alzheimer's symptoms such as memory loss and senile dementia. Find out about Alzheimer's stages, causes and new treatments. Jan 22, 2021 · Treatment for Alzheimer's disease, the devastating condition that affects more than 5 million Americans, has remained notoriously elusive for decades. Now, a small study released by drug company Eli Lilly offers at least a flicker of hope: It shows that the experimental drug donanemab may significantly slow patients’ cognitive decline. It is the first approved treatment to attack the disease process of Alzheimer’s instead of just addressing dementia symptoms. Biogen, its manufacturer, announced Monday afternoon that the list ...Ask the Doctor About Medicine. The FDA hasn't approved any drugs for dementia-related psychosis. Doctors often prescribe atypical, or second-generation antipsychotics meant to help with ... In the early stages of Alzheimer's, the person with dementia may need help remembering to take medications. As a caregiver, you may find it helpful to: Use a pill box organizer. Using a pill box or keeping a daily list or calendar can help ensure medication is taken as prescribed. Develop a routine for giving the medication.Huperzine A. Huperzine A (pronounced HOOP-ur-zeen) is a moss extract that has been used in traditional Chinese medicine for centuries. It has properties similar to those of cholinesterase inhibitors, one class of FDA-approved Alzheimer's medications. As a result, it is promoted as a treatment for Alzheimer's disease.The most common treatment for depression in Alzheimer's involves a combination of medicine, counseling, and gradual reconnection to activities and people that bring happiness. Simply telling the person with Alzheimer's to "cheer up," "snap out of it" or "try harder" is seldom helpful. Apr 24, 2023 · Alzheimer’s disease is a progressive neurodegenerative disorder that affects memory, thinking, behavior, and ultimately, a person’s ability to carry out daily activities. Aug 19, 2023 · Drugs are the cornerstone of treatment for Alzheimer’s disease. The current medications cannot stop or cure Alzheimer's but may slow the progression of the disease and improve symptoms. Some drugs (like cholinesterase inhibitors) work by improving communication between nerve cells, while others (like antidepressants) may help with behavioral ... Jun 7, 2021 · June 07, 2021. Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was ... Matt York/AP. The Food and Drug Administration approved the drug aducanumab to treat patients with Alzheimer's disease on Monday. It is the first new drug approved by the agency for Alzheimer's ...Treatments. There's no cure for Alzheimer’s, but there are treatments that may change disease progression, and drug and non-drug options that may help treat symptoms. Understanding available options can help individuals living with the disease and their caregivers to cope with symptoms and improve quality of life. January 06, 2023. Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the ...Jan 11, 2023 · On January 6th, the Food and Drug Administration approved, via the Accelerated Approval pathway, a new treatment for Alzheimer’s disease called Leqembi. While older Alzheimer’s drugs may ease symptoms for a time, they do nothing to stop the relentless downward course of the disease. Leqembi is the second of a ... Manage medications. Some antidepressant medications, such as bupropion and venlafaxine, can lead to insomnia. Cholinesterase inhibitors, such as donepezil, can improve cognitive and behavioral symptoms in people with Alzheimer's but also can cause insomnia. If the person with dementia is taking these kinds of medications, talk to the doctor.Alzheimer disease most commonly affects older adults, but it can also affect people in their 30s or 40s. When Alzheimer disease occurs in someone under age 65, it is known as early-onset (or younger-onset) Alzheimer disease. A very small number of people with Alzheimer disease have the early-onset form. Many of them are in their 40s and 50s ...Jun 7, 2021 · The Food and Drug Administration on Monday approved Biogen ’s Alzheimer’s disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people ... 3 commonly prescribed cholinesterase inhibitors: Aricept (donepezil) is approved for all stages of Alzheimer’s. Exelon (rivastigmine) is approved for mild to moderate Alzheimer’s. Razadyne (galantamine) is approved for mild to moderate Alzheimer’s. Side effects include nausea, vomiting, loss of appetite, and increased frequency of bowel ... .
